http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019504891-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-636 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-52 |
| filingDate | 2017-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019504891-A |
| titleOfInvention | Use of trehalose to treat neurological disorders |
| abstract | The present disclosure discloses trehalose for use in the treatment of neurological disorders, wherein trehalose is for a single daily administration with a daily dose of about 0.25 to about 12.5 g / kg / day. The daily dose can be about 2.67 g / kg / day. Disclosed is a method for treating a neurological disorder comprising administering trehalose to a subject as a single daily dose with a daily dose of about 0.25 to about 12.5 g / kg / day, and one implementation of the method In form, the daily dose is about 2.67 g / kg / day. Further disclosed herein is the use of trehalose in the manufacture of a medicament for treating neurological disorders, wherein trehalose is present in the medicament in an amount of about 0.25 to about 12.5 g / kg / day. Formulated as a single daily dose. In one embodiment, the daily dose is about 2.67 g / kg / day. The present disclosure provides a pharmaceutical composition for treating neuropathy comprising a daily dose of trehalose and a pharmaceutically acceptable carrier, wherein the daily dose of trehalose is about 0.25 to about 12.5 g / kg. It is. Trehalose can be formulated as part of a food product. [Selection] Figure 1 |
| priorityDate | 2016-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.